admin

Heme oxygenase-1 modulation: A potential therapeutic target for COVID-19 and associated complications

Admin19 October 2020

Author links open overlay panel Devendra Singh Himika Wasan K.H.Reeta Department of Pharmacology, All India Institute of Medical Sciences, New ... Read More

Safety and Mode of Action of Diabetes Medications in comparison with 5-Aminolevulinic Acid (5-ALA)

Admin6 November 2019

Peter R. Rehani,1 Hanaa Iftikhar,2 Motowo Nakajima,3 Tohru Tanaka,3 Zaid Jabbar,4 and Riyadh N. Rehani5 Conclusion: The provided analysis of the different mechanisms of action of ... Read More

Announced the results of joint research on the development of a treatment for mitochondrial disease using 5-aminolevulinic acid and sodium ferrous citrate

Admin9 August 2019

SBI Pharma Co., Ltd. Saitama Medical University Chiba Children’s Hospital Juntendo University SBI Pharma Co., Ltd. (Location: Minato-ku, Tokyo, President: ... Read More

Oral administration of 5-aminolevulinic acid induces heme oxygenase-1 expression in peripheral blood mononuclear cells of healthy human subjects in combination with ferrous iron

Admin10 May 2018

Author links open overlay panel HidenoriItoa1, YoshiakiNishiob1, TakeshiHaraa, HidemitsuSugiharaa, TohruTanakaa, Xiao-KangLib SBI Pharmaceuticals Co., Ltd., 1-6-1 Roppongi, Minato-ku, Tokyo 106-6020 ... Read More

Heme oxygenase-1 modulation: A potential therapeutic target for COVID-19 and associated complications

Safety and Mode of Action of Diabetes Medications in comparison with 5-Aminolevulinic Acid (5-ALA)

Announced the results of joint research on the development of a treatment for mitochondrial disease using 5-aminolevulinic acid and sodium ferrous citrate

Oral administration of 5-aminolevulinic acid induces heme oxygenase-1 expression in peripheral blood mononuclear cells of healthy human subjects in combination with ferrous iron

Make an enquiry